Journal article icon

Journal article

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial

Abstract:

To determine the proportion of patients with psoriatic arthritis in the Adalimumab Effectiveness in Psoriatic Arthritis trial achieving minimal disease activity (MDA) and its individual components at 1 or more visits over 144 weeks, identify baseline predictors of MDA achievement, and evaluate the association of MDA status with independent quality of life (QoL)-related patient-reported outcomes (PROs).Univariate and multivariate analyses were used to identify the baseline characteristics that...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/rmdopen-2016-000415

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
ORCID:
0000-0002-4756-663X
Expand authors...
Publisher:
BMJ Publishing Group Publisher's website
Journal:
RMD Open Journal website
Volume:
3
Issue:
1
Article number:
e000415
Publication date:
2017-07-18
Acceptance date:
2017-06-12
DOI:
EISSN:
2056-5933
Pmid:
29225916
Source identifiers:
1007812
Language:
English
Keywords:
Pubs id:
pubs:1007812
UUID:
uuid:c68a6b99-49c1-4216-8a2c-fc83220c99c5
Local pid:
pubs:1007812
Deposit date:
2019-07-01

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP